By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

OK

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

Teva

Teva Pharmaceuticals shares phase 3 data for Ajovy as migraine treatment Pharmafile06:39Ajovy Obesity Pharma

Teva’s Ajovy yields positive data in post-hoc migraine analysis Clinical Trials Arena06:21Ajovy Obesity Pharma

Teva Pharmaceutical analysts boost target price as brand transition underway Proactive Investors (US)15:55UBS Pharma Nasdaq

Teva Pharma 'uniquely positioned,' Jazz Pharmaceuticals set-up balanced - UBS Investing.com11:29UBS Pharma Nasdaq

Teva and Sanofi conclude collaboration deal for anti-TL1A therapy Pharmaceutical Technology05:10Sanofi Pharma

Teva closes collaboration deal with Sanofi on IBD treatment MarketWatch08:58Sanofi Pharma

N.C. to receive $1.4B in opioid settlements with Teva, Allergan, CVS and Walgreens Fox Wilmington02:21Walgreens CVS Pharma

Teva drops migraine-drug patent case against Eli Lilly Reuters15:03Pharma Eli Lilly Business (US)

Teva gets appeals court to review $10 billion kickback dispute Bloomberg Law09:45Pharma Health

Latest News

Earlier today

Turn Gaza border area into model of sustainable development, green organization says The Times of Israel03:27

In the last 7 days

N.C. to receive $1.4B in opioid settlements with Teva, Allergan, CVS and Walgreens Fox Wilmington02:21 8-Dec-23

Teva: 4 Key Drivers For A 2024 Revival (Upgraded Rating) Seeking Alpha01:54 8-Dec-23

Teva Says EpiPen Suit Only Remedy For Colo. Takings Law36022:14 7-Dec-23

FDA posts a flurry of voluntary drug recalls by Teva, Glenmark, Apotex and VistaPharm FiercePharma10:04 7-Dec-23

Meniscus Tear Market Growth Anticipated by 2032 | Major Players: Merck, Teva Pharmaceutical,… Industry Today07:11 7-Dec-23

Lumbosacral Radicular Pain Market Growth Anticipated by 2032 | Major Players: Scilex… Industry Today07:11 7-Dec-23

Health Canada approves FYB201/Ranopto® (Ranibizumab), a biosimilar to Lucentis® DGAP01:31 7-Dec-23

Interstitial Cystitis Market Growth Anticipated by 2032 | Major Players: Merck, Teva… Industry Today08:27 6-Dec-23

Teva Pharmaceuticals shares phase 3 data for Ajovy as migraine treatment Pharmafile06:39 6-Dec-23

Teva’s Ajovy yields positive data in post-hoc migraine analysis Clinical Trials Arena06:21 6-Dec-23

New Post Hoc Phase 3 Data Analysis Shows AJOVY® (fremanezumab) Reduced Migraine Attacks in Adults with Mi Teva Pharmaceutical Industries (Press Releases)02:36 6-Dec-23

New Post Hoc Phase 3 Data Analysis Shows AJOVY® (fremanezumab) Reduced Migraine Attacks in… Business Wire (Press Release)02:06 6-Dec-23

Class 4 Medicines Notification: Teva UK Ltd., Caramet 25/100mg CR Tablets, EL(23)A/40 GOV.UK (Press Release)06:12 4-Dec-23

In the last month

Teva and Sanofi conclude collaboration deal for anti-TL1A therapy Pharmaceutical Technology05:10 1-Dec-23

Teva Closes Collaboration Deal With Sanofi on IBD Treatment MarketWatch08:58 30-Nov-23

Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease… Business Wire (Press Release)08:32 30-Nov-23

Teva drops patent case against Lilly after two Ajovy patents deemed invalid FiercePharma12:11 28-Nov-23

UBS upgrades Teva due to "attractive brand assets" Globes11:24 28-Nov-23

Star Wars' Canceled TV Show Is More Important Than Ever - & The MCU Has Shown How To Tell The… ScreenRant09:39 28-Nov-23

Teva, Eli Lilly Call Off Infringement Suit Over Migraine Drug Law36019:29 27-Nov-23

Teva Pharmaceutical analysts boost target price as brand transition underway Proactive Investors (US)15:55 27-Nov-23

Teva Pharma 'uniquely positioned,' Jazz Pharmaceuticals set-up balanced - UBS Investing.com11:29 27-Nov-23

Teva Pharmaceutical upgraded to 'Buy' at UBS Yahoo! US10:31 27-Nov-23

Global Glioma Treatment Market Report 2023-2027 and 2032 Featuring Major Players - Merck & Co, Amgen, F Hoffmann-La… GlobeNewswire (Press Release)07:55 27-Nov-23

Roku raised to Buy, YPF extends gains following upgrade: 4 big analyst picks Investing.com07:25 27-Nov-23

Canada bans arm of drugmaker Teva from federal contracts over U.S. price-fixing scheme The Province, British Columbia06:09 27-Nov-23

Teva drops migraine-drug patent case against Eli Lilly Reuters15:03 24-Nov-23

Teva, Allergan, CVS, and Walgreens Finalize Opioid Settlement Agreements Office of the Vermont Attorney General (Press Release)08:40 22-Nov-23

UGG, Teva Maker Files Suits Against Costco, Zoetop, Shein Bloomberg Law08:27 22-Nov-23

Teva granted pretrial appeal in high-stakes Copaxone kickbacks case FiercePharma09:44 21-Nov-23

Colo. Says 11th Amendment Shields It From Teva EpiPen Suit Law36021:01 20-Nov-23

Teva to Present at the 6th Annual Evercore ISI HealthCONx Conference Business Wire (Press Release)16:35 20-Nov-23

Teva: Deeply Undervalued FCF Machine Seeking Alpha16:24 20-Nov-23

The Mandalorian Star Celebrates His Ahsoka Cameo & Promises The Best Is Yet To Come ScreenRant14:57 20-Nov-23

Teva Gets Appeals Court to Review $10 Billion Kickback Dispute Bloomberg Law09:45 20-Nov-23

'Pretty alarmed': Thousands of Kiwis with ADHD forced to switch drugs after supply problems New Zealand Herald11:20 19-Nov-23

1st Circ. To Review Crucial Issue In Teva, Regeneron Cases Law36021:20 17-Nov-23

Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S. Business Wire (Press Release)08:34 17-Nov-23

Tesla applies to be an electricity retailer in Australia Teslarati23:11 16-Nov-23

TEVA, Royalty Pharma Sign Funding Deal for Schizophrenia Drug Zacks08:33 14-Nov-23

Teva and Royalty Pharma to expedite olanzapine LAI research programme Pharmaceutical Technology06:20 14-Nov-23

Corcept, Teva Exchange Blows Over Post-Trial Evidence ‘Ambush’ Bloomberg Law17:35 13-Nov-23

BofA more confident in Teva Pharma after management meetings Investing.com13:36 13-Nov-23

Teva draws $100M from Royalty funding to bankroll long-acting schizophrenia drug FiercePharma11:53 13-Nov-23

Teva signs $125m deal with Royalty Pharma on antipsychotic drug Globes11:47 13-Nov-23

Half a year later, Teva's 'pivot to growth' strategy appears to be bearing fruit FiercePharma11:32 13-Nov-23

Teva's new royalty deal; Selecta merges with Cartesian; Vir's hepatitis data ENDPOINTS11:05 13-Nov-23

MedinCell Applauds Teva and Royalty Pharma Collaboration to Further Accelerate Olanzapine LAI… Business Wire (Press Release)09:43 13-Nov-23

Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program GlobeNewswire (Press Release)08:12 13-Nov-23

Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program Business Wire (Press Release)08:02 13-Nov-23

How Proskauer's Bart Williams Helped Land a Defense Verdict in Gilead Pay-for-Delay Antitrust Case Proskauer Rose LLP15:09 10-Nov-23

view more headlines

10 Dec 03:27

Teva News

NewsNow brings you the latest news from the world’s most trusted sources on Teva. NewsNow aims to be the world’s most accurate and comprehensive Teva news aggregator, bringing you the latest headlines automatically and continuously 24/7.

Publication filters

Notifications

Unsubscribe from Breaking News

Sorry, no headlines or news topics were found. Please try different keywords.